Awareness for good practices on antimicrobial usage to safeguard One Health and the impact of the new veterinary regulationAfterthoughs
In the race against antimicrobial resistance the balance has shifted from ignorance to ineptitude. A misapprehension of the modern applications in veterinary medicine could jeopardize scientific endeavours to resolve antimicrobial resistance. What might be the consequences of the new Veterinary Medicinal Products Regulation on the one health approach? What solutions do we have today to improve antibiotic usage?
1st EVAC's program
Antibiotic resistance is a significant issue. Unfortunately, today
the only emphasis is set on antimicrobial reduction instead of
correct usage. At this moment Colistin is again subject to be banned
based on questionable criteria. Moreover, correct usage of antibiotics
can reduce to even eliminate the risk of selecting for antimicrobial
resistance. This is relevant not only for novel antibiotics but
also for generic compounds.
The misconception on antimicrobial resistance
The example of Colistin
Critical view on antimicrobial developments
Are the recommendations for the future still relevant?
"In a philosophy of limits, calculated ignorance and risk, he who cannot know everything has no right to ban everything"
- Albert Camus (nobel prize in Literature, 1957) -
DVM, DSc, DipECVPT
Thirty years of experience within the animal and human pharmaceutical industry as director of toxicology and/or general pharmacology departments or as Consultant for major pharmaceutical/feed additives companies or national firms. Supervision of hundreds of R&D projects, leading to Approval by regulatory authorities of a number of new products currently on the market (feed additives, veterinary drugs, biocidal products).
DVM, Field practitioner
Dr. Chatenet is a veterinarian and bird expert with more than two decades of field experience. Between 2010 and 2019 he travelled the world to give seminars and trainings to avail poultry health and improve management practices. The past six months Dr. Chatenet devoted his time to bring practical insights to the pharmaceutical industry and initiated the development of a field test to detect for resistance genes in bacteria.
Dr. Boudewijn Catry
Head Healthcare associated Infections & antimicrobial resistance (Belgium Gov)
Ass. Prof Epidemiology - ULB
Dr. Boudewijn Catry (DVM °2000, PhD °2005) is a researcher with a special interest in antimicrobial resistance, both in veterinary and human medicine. Between 2000 and 2007, he combined ambulatory practice & obstetrics as a veterinary surgeon with laboratory research at the Ghent University (Ugent). Hereafter he started to work at Sciensano where he is since 2009 in charge of the service Healthcare associated Infections & Antimicrobial Resistance (www.nsih.be). He is involved in national and international committees on the prudent use of antimicrobials and infection prevention. He is co-founder (°2013) of the outbreak support team for multidrug resistant organisms in Belgian hospitals (MDRO-OST). Since 2018 he is lecturer epidemiology at the Faculty of Medicine in Brussels (Université libre de Bruxelles,ULB).